Results 211 to 220 of about 2,562,087 (294)

Migration status and urologic health inequities: a scoping review. [PDF]

open access: yesCurr Opin Urol
Goodarzi K   +4 more
europepmc   +1 more source

Lesion‐targeted transurethral ultrasound ablation for MRI‐visible localised prostate cancer: 12‐month phase II results

open access: yesBJU International, EarlyView.
Objectives To evaluate oncological efficacy and safety of transurethral ultrasound ablation (TULSA) treatment, we defined the co‐primary endpoints as the absence of International Society of Urological Pathology Grade Group (ISUP GG) ≥2 cancer at 12‐month biopsy and the absence of Clavien–Dindo Grade ≥III complications within 3 months, while secondary ...
Eemil Yli‐Pietilä   +10 more
wiley   +1 more source

Impact of surgical start time on clinical outcomes in urologic surgery: a single-center study of major oncologic surgeries and adrenalectomy. [PDF]

open access: yesWorld J Urol
Kobatake K   +8 more
europepmc   +1 more source

Body mass index, waist circumference and association to surgical margins after radical prostatectomy

open access: yesBJU International, EarlyView.
Objective To investigate obesity in association with risk of positive surgical margins (PSM) after radical prostatectomy (RP) for prostate cancer. Patients and methods We used data from Swedish cohorts and registers linked to the National Prostate Cancer Register to identify men who had undergone RP between 2007 and 2021.
Katarina Tomic   +13 more
wiley   +1 more source

Continuous vs stent‐removal antibiotic prophylaxis after cystectomy: a retrospective analysis

open access: yesBJU International, EarlyView.
Objectives To compare the efficacy and microbiological consequences of continuous prophylaxis (CP) vs stent‐removal prophylaxis (SRP) in patients undergoing cystectomy with urinary diversion. Patients and Methods This single‐centre retrospective cohort study included 223 patients undergoing cystectomy with urinary diversion from 2015 to 2024.
Sam McDonald   +7 more
wiley   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Treatment-related Risk of Urologic Adverse Events in Cervical Cancer Survivors. [PDF]

open access: yesUrology
Powell J   +5 more
europepmc   +1 more source

Triggering SORL1 Expression Restricts ccRCC Progression by Inducing Ubiquitination‐Mediated c‐Myc Degradation

open access: yesCancer Science, EarlyView.
Targeted triggering of SORL1 expression through a novel MPOC delivery system could inhibit ccRCC progression through binding to TRIM22 and further promoting ubiquitination‐mediated C‐MYC degradation, thereby facilitating the inhibition of oxidative phosphorylation through transcriptional repression of ACO2 and IDH2.
Keyi Wang   +11 more
wiley   +1 more source

Urological Diseases of Pregnancy

open access: yesAmerican Journal of Clinical Pathology, 1942
openaire   +2 more sources

Home - About - Disclaimer - Privacy